Case number 1:22-cv-00164
Acerta Pharma B.V. et al v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2022 | 33 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to paragraph 4(a) of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jun 22, 2022 | 32 | Certification for Jihad Komis (1) |
| Jun 22, 2022 | 32 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certification for Jihad Komis)(Joyce, Alexandra) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 22-cv-155-RGA; 28 in 22-cv-163-RGA; 36 in 22-cv-154-RGA; 32 in 22-cv-164-RGA; 32 in 22-cv-162-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 31 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 1/9/2023. Amended Pleadings due by 1/9/2023. Fact Discovery completed by 2/12/2024. Joint Claim Construction Brief due by 7/31/2023. A Markman Hearing is set for 8/31/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial on invalidity is set to start 3/3/2025, at 8:30 AM in Courtroom 6A. One day Bench Trials on infringement is set to start 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 30 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/13/2022 (nms). |
| May 11, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 5/11/2022. Counsel for Plaintiffs: A. Joyce. Counsel for Defendants: D. Gattuso, M. Haney, M. Goeller. A 3-day Bench Trial on Invalidity is scheduled to begin on 3/3/2025. A Pretrial Conference is set for 2/21/2025, at 9:00 AM. Plaintiff's are directed to resubmit the proposed scheduling order reflecting the rulings the Court made during the hearing. (Court Reporter Heather Triozzi.) Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(lak) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 22-cv-155-RGA; D.I. 28 in 22-cv-154-RGA; D.I. 29 in 22-cv-164-RGA; D.I. 29 in 22-cv-162-RGA; D.I. 24 in 22-cv-163-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 5/10/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 10, 2022 | 29 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, and Merck Sharp & Dohme B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 9, 2022 | 28 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Alexandra M. Joyce, Esq. regarding Dial-In for Rule 16 Teleconference. (Joyce, Alexandra) |
| May 9, 2022 | 27 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/10/2022 (nms). |
| Apr 29, 2022 | 26 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 28, 2022 | 25 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the Deadline for Plaintiffs to Answer, Move, or Respond to the Counterclaims to May 16, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Apr 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 25 in 22-cv-162-RGA; D.I. 25 in 22-cv-164-RGA; D.I. 24 in 22-cv-154-RGA; D.I. 19 in 22-cv-163-RGA) STIPULATION and Proposed Order to Extend Time to Answer, Move, or Respond to the Counterclaims to May 16, 2022. Signed by Judge Richard G. Andrews on 4/28/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Apr 18, 2022 | 24 | Certificate of Service (1) |
| Apr 18, 2022 | 24 | Exhibit C (3) |
| Apr 18, 2022 | 24 | Main Document (64) Docket Text: REDACTED VERSION of [15] Answer to Complaint,, Counterclaim, by Sandoz Inc.. (Attachments: # (1) Exhibit C, # (2) Certificate of Service)(Gattuso, Dominick) |
| Apr 18, 2022 | 23 | Order (1) Docket Text: ORDER Granting [14] Unopposed Motion for Leave to File Under Seal. Signed by Judge Richard G. Andrews on 4/18/2022. (nms) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The exhibits A, B, and D found at D.I. [15] are STRUCK. Ordered by Judge Richard G. Andrews on 4/18/2022. (nms) |
| Apr 13, 2022 | 21 | Redacted Document (2) Docket Text: REDACTED VERSION of [20] Letter by Sandoz Inc.. (Gattuso, Dominick) |
| Apr 13, 2022 | 19 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/11/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/13/2022. (nms) |
| Apr 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties shall jointly respond as to why the Court shouldn't strike Exhibits A, B, and D as unnecessary to Defendant's answer. Ordered by Judge Richard G. Andrews on 4/12/2022. (nms) |
| Apr 12, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 16 has been removed from the docket. Exhibit C filed at that entry has been added to D.I. 15. This makes the filing at D.I. 15 more cohesive. It is expected and understood that when Defendant files a redacted version of D.I. 15 no part of Exhibit C will be redacted. (nms) |
| Apr 11, 2022 | 14 | Text of Proposed Order (1) |
| Apr 11, 2022 | 14 | Main Document (3) Docket Text: Unopposed Motion for Leave to File Under Seal - filed by Sandoz Inc.. (Attachments: # (1) Proposed Order)(Gattuso, Dominick) Modified on 4/12/2022 (nms). |
| Apr 11, 2022 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) |
| Apr 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 31, 2022 | 13 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Sharon Lin of Winston & Strawn LLP - filed by Sandoz Inc.. (Gattuso, Dominick) |
| Mar 31, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Jovial Wong, Sharon Lin for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Mar 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Sharon Lin of Winston & Strawn LLP, filed by Sandoz Inc.. Signed by Judge Richard G. Andrews on 3/31/2022. (nms) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin Hoagland-Hanson, Min Kyung Jeon, Stanley E. Fisher, David I. Berl, and Sarahi Uribe for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(smg) |
| Feb 17, 2022 | 12 | Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sar (5) |
| Feb 17, 2022 | 12 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon)(Joyce, Alexandra) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 22-cv-164-RGA; 11 in 22-cv-155-RGA; 11 in 22-cv-162-RGA; 11 in 22-cv-163-RGA; 11 in 22-cv-154-RGA) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 2/17/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Feb 9, 2022 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to April 11, 2022 - filed by Sandoz Inc.. (Gattuso, Dominick) |
| Feb 9, 2022 | 10 | Exhibit A-B (7) |
| Feb 9, 2022 | 10 | Main Document (2) Docket Text: DECLARATION of Service of Sandoz Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | 9 | Exhibit A-B (7) |
| Feb 9, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service of Sandoz Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Granting [11] STIPULATION and Order to Extend Time to answer, move or otherwise respond to the Complaint (*Reset Answer Deadlines: Sandoz Inc. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 2/9/2022. (nms) |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA (rjb) |
| Feb 7, 2022 | 8 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Sandoz Inc. on 2/7/2022. (mal) |
| Feb 4, 2022 | 1 | Main Document (27) Docket Text: COMPLAINT filed against Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3796417.) - filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal) |
| Feb 4, 2022 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V.. (mal) |
| Feb 4, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Limited. (mal) |
| Feb 4, 2022 | 5 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (mal) |
| Feb 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,290,504 ;9,758,524 ;10,239,883 ;9,796,721 ;10,167,291. (mal) |
| Feb 4, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/28/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: No earlier than 4/30/2025. (mal) |
| Feb 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Feb 4, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 4, 2022 | 1 | Exhibit A-F (608) |
| Feb 4, 2022 | 1 | Complaint* (1) |
